Effect of prolonged bivalirudin infusion on ST-segment resolution following primary percutaneous coronary intervention (from the PROBI VIRI 2 Study)

American Journal of Cardiology

Volumn 108, Issue 9, 2011, Pages 1220-1224

  Cortese, Bernardo ^a   Limbruno, Ugo ^b   Severi, Silva ^b   De Matteis, Sara ^c   Diehl, Livia ^d   Pitì, Antonio ^a,e  

^a Humanitas Gavazzeni Hospital   (Italy)

^b MISERICORDIA HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

^e TREVIGLIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BLEEDING; CONTINUOUS INFUSION; CONTROLLED STUDY; DATA BASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG ELUTING STENT; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOSIS PREVENTION; THROMBUS; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HEMORRHAGE; HEPARIN; HIRUDINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; POSTOPERATIVE CARE; RECOMBINANT PROTEINS;

EID: 80054693032     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.06.033     Document Type: Article

References (11)

1. R. Mehran, A.J. Lansky, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, S.C. Wong, E. Nikolsky, L. Gambone, L. Vandertie, H. Parise, G.D. Dangas, and G.W. Stone Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
2. B. Cortese, A. Picchi, A. Micheli, A.G. Ebert, F. Parri, S. Severi, and U. Limbruno Comparison of prolonged bivalirudin infusion versus intraprocedural in preventing myocardial damage after percutaneous coronary intervention in patients with angina pectoris Am J Cardiol 104 2009 1063 1068
3. B. Cortese, A. Micheli, A. Picchi, L. Bandinelli, M.G. Brizi, S. Severi, and U. Limbruno Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study Coron Artery Dis 20 2009 348 353
4. G.W. Stone, B.T. McLaurin, D.A. Cox, M.E. Bertrand, A.M. Lincoff, J.W. Moses, H.D. White, S.J. Pocock, J.H. Ware, F. Feit, A. Colombo, P.E. Aylward, A.R. Cequier, H. Darius, W. Desmet, R. Ebrahimi, M. Hamon, L.H. Rasmussen, H.J. Rupprecht, J. Hoekstra, R. Mehran, and E.M. Ohman Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216 (Pubitemid 44791162)
5. A. Marzocchi, A. Manari, G. Piovaccari, C. Marrozzini, S. Marra, P. Magnavacchi, P. Sangiorgio, L. Marinucci, N. Taglieri, G. Gordini, N. Binetti, V. Guiducci, N. Franco, M.L. Reggiani, and F. Saia Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the Facilitated Angioplasty with Tirofiban or Abciximab (FATA) in ST-elevation myocardial infarction trial Eur Heart J 29 2008 2972 2980
6. F.A. Cura, M. Roffi, N. Pasca, K.E. Wolski, A.M. Lincoff, E.J. Topol, and M.S. Lauer ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy) Am J Cardiol 94 2004 859 863 (Pubitemid 39349547)
7. J.D. Haeck, N.J. Verouden, W.J. Kuijt, K.T. Koch, M. Majidi, A. Hirsch, J.G. Tijssen, M.W. Krucoff, and R.J. De Winter Impact of early, late, and no ST-segment resolution measured by continuous ST Holter monitoring on left ventricular ejection fraction and infarct size as determined by cardiovascular magnetic resonance imaging J Electrocardiol 44 2011 36 41
8. C.E. Buller, Y. Fu, K.W. Mahaffey, T.G. Todaro, P. Adams, C.M. Westerhout, H.D. White, A.W. van' t Hof, F.J. Van de Werf, G.S. Wagner, C.B. Granger, and P.W. Armstrong ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial Circulation 118 2008 1335 1346
9. R. Schroder, K. Wegscheider, K. Schroder, R. Dissmann, and W. Meyer-Sabellek Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial J Am Coll Cardiol 26 1995 1657 1664
10. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M.F. Piepoli, C. Pirlet, J.L. Pomar, N. Reifart, F.L. Ribichini, M.J. Schalij, P. Sergeant, P.W. Serruys, S. Silber, M. Sousa Uva, D. Taggart, A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, P.E. Vardas, P. Widimsky, O. Alfieri, J. Dunning, S. Elia, P. Kappetein, U. Lockowandt, G. Sarris, P. Vouhe, L. von Segesser, S. Agewall, A. Aladashvili, D. Alexopoulos, M.J. Antunes, E. Atalar, A. Brutel de la Riviere, A. Doganov, J. Eha, J. Fajadet, R. Ferreira, J. Garot, J. Halcox, Y. Hasin, S. Janssens, K. Kervinen, G. Laufer, V. Legrand, S.A. Nashef, F.J. Neumann, K. Niemela, P. Nihoyannopoulos, M. Noc, J.J. Piek, J. Pirk, Y. Rozenman, M. Sabate, R. Starc, M. Thielmann, D.J. Wheatley, S. Windecker, and M. Zembala Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
11. C.M. Gibson, D.A. Morrow, S.A. Murphy, T.M. Palabrica, L.K. Jennings, P.H. Stone, H.H. Lui, T. Bulle, N. Lakkis, R. Kovach, D.J. Cohen, P. Fish, C.H. McCabe, and E. Braunwald A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial J Am Coll Cardiol 47 2006 2364 2373 (Pubitemid 43884775)